Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 270


Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse.

Ando Y, Yang GX, Kenny TP, Kawata K, Zhang W, Huang W, Leung PS, Lian ZX, Okazaki K, Ansari AA, He XS, Invernizzi P, Ridgway WM, Lu Q, Gershwin ME.

J Autoimmun. 2013 Mar;41:111-9. doi: 10.1016/j.jaut.2012.12.013. Epub 2013 Feb 8.


Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.

Yang GX, Lian ZX, Chuang YH, Moritoki Y, Lan RY, Wakabayashi K, Ansari AA, Flavell RA, Ridgway WM, Coppel RL, Tsuneyama K, Mackay IR, Gershwin ME.

Hepatology. 2008 Jun;47(6):1974-82. doi: 10.1002/hep.22226.


B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis.

Moritoki Y, Zhang W, Tsuneyama K, Yoshida K, Wakabayashi K, Yang GX, Bowlus C, Ridgway WM, Ueno Y, Ansari AA, Coppel RL, Mackay IR, Flavell RA, Gershwin ME, Lian ZX.

Gastroenterology. 2009 Mar;136(3):1037-47. doi: 10.1053/j.gastro.2008.11.035. Epub 2008 Nov 19.


Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice.

Yoshida K, Yang GX, Zhang W, Tsuda M, Tsuneyama K, Moritoki Y, Ansari AA, Okazaki K, Lian ZX, Coppel RL, Mackay IR, Gershwin ME.

Hepatology. 2009 Nov;50(5):1494-500. doi: 10.1002/hep.23132.


Successful treatment of murine autoimmune cholangitis by parabiosis: Implications for hematopoietic therapy.

Yang JB, Wang YH, Yang W, Lu FT, Ma HD, Zhao ZB, Jia YJ, Tang W, Tsuneyama K, Ridgway WM, Gershwin ME, Lian ZX.

J Autoimmun. 2016 Jan;66:108-17. doi: 10.1016/j.jaut.2015.09.002. Epub 2015 Oct 1.


Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells.

Huang W, Kachapati K, Adams D, Wu Y, Leung PS, Yang GX, Zhang W, Ansari AA, Flavell RA, Gershwin ME, Ridgway WM.

J Autoimmun. 2014 May;50:123-34. doi: 10.1016/j.jaut.2014.01.034. Epub 2014 Feb 18.


Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3(+) regulatory T cells.

Tanaka H, Zhang W, Yang GX, Ando Y, Tomiyama T, Tsuneyama K, Leung P, Coppel RL, Ansari AA, Lian ZX, Ridgway WM, Joh T, Gershwin ME.

Clin Exp Immunol. 2014 Nov;178(2):253-61. doi: 10.1111/cei.12415.


Beta-glucosylceramide ameliorates liver inflammation in murine autoimmune cholangitis.

Zhang W, Moritoki Y, Tsuneyama K, Yang GX, Ilan Y, Lian ZX, Gershwin ME.

Clin Exp Immunol. 2009 Sep;157(3):359-64. doi: 10.1111/j.1365-2249.2009.03971.x.


Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice.

Oertelt S, Lian ZX, Cheng CM, Chuang YH, Padgett KA, He XS, Ridgway WM, Ansari AA, Coppel RL, Li MO, Flavell RA, Kronenberg M, Mackay IR, Gershwin ME.

J Immunol. 2006 Aug 1;177(3):1655-60.


Truncated form of TGF-βRII, but not its absence, induces memory CD8+ T cell expansion and lymphoproliferative disorder in mice.

Ishigame H, Mosaheb MM, Sanjabi S, Flavell RA.

J Immunol. 2013 Jun 15;190(12):6340-50. doi: 10.4049/jimmunol.1300397. Epub 2013 May 17.


Endogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice.

Yang GX, Sun Y, Tsuneyama K, Zhang W, Leung PS, He XS, Ansari AA, Bowlus C, Ridgway WM, Gershwin ME.

Clin Exp Immunol. 2016 Aug;185(2):154-64. doi: 10.1111/cei.12806. Epub 2016 Jun 6.


Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis.

Zhang W, Tsuda M, Yang GX, Tsuneyama K, Rong G, Ridgway WM, Ansari AA, Flavell RA, Coppel RL, Lian ZX, Gershwin ME.

Hepatology. 2010 Jul;52(1):215-22. doi: 10.1002/hep.23664.


Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFβRII mice.

Kawata K, Yang GX, Ando Y, Tanaka H, Zhang W, Kobayashi Y, Tsuneyama K, Leung PS, Lian ZX, Ridgway WM, Ansari AA, He XS, Gershwin ME.

Hepatology. 2013 Sep;58(3):1094-104. doi: 10.1002/hep.26418. Epub 2013 Jul 24.


Aberrant TGF-β1 signaling contributes to the development of primary biliary cirrhosis in murine model.

Liu B, Zhang X, Zhang FC, Zong JB, Zhang W, Zhao Y.

World J Gastroenterol. 2013 Sep 21;19(35):5828-36. doi: 10.3748/wjg.v19.i35.5828.


Immunological potential of cytotoxic T lymphocyte antigen 4 immunoglobulin in murine autoimmune cholangitis.

Tanaka H, Yang GX, Tomiyama T, Tsuneyama K, Zhang W, Leung PS, Coppel RL, Joh T, Nadler SG, Ansari AA, Bowlus C, Gershwin ME.

Clin Exp Immunol. 2015 Jun;180(3):371-82. doi: 10.1111/cei.12581.


Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosis.

Kawata K, Tsuda M, Yang GX, Zhang W, Tanaka H, Tsuneyama K, Leung P, He XS, Knechtle S, Ansari AA, Coppel RL, Gershwin ME.

PLoS One. 2013 Sep 10;8(9):e74225. doi: 10.1371/journal.pone.0074225. eCollection 2013.


Role of T cell TGF-beta signaling in intestinal cytokine responses and helminthic immune modulation.

Ince MN, Elliott DE, Setiawan T, Metwali A, Blum A, Chen HL, Urban JF, Flavell RA, Weinstock JV.

Eur J Immunol. 2009 Jul;39(7):1870-8. doi: 10.1002/eji.200838956.


Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis.

Chuang YH, Lian ZX, Yang GX, Shu SA, Moritoki Y, Ridgway WM, Ansari AA, Kronenberg M, Flavell RA, Gao B, Gershwin ME.

Hepatology. 2008 Feb;47(2):571-80.


The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II mice.

Ando Y, Yang GX, Tsuda M, Kawata K, Zhang W, Nakajima T, Tsuneyama K, Leung P, Lian ZX, Okazaki K, Ridgway WM, Norman GL, Ansari AA, He XS, Coppel RL, Gershwin ME.

Hepatology. 2012 Oct;56(4):1418-26. doi: 10.1002/hep.25803.


Krüppel-like factor KLF10 regulates transforming growth factor receptor II expression and TGF-β signaling in CD8+ T lymphocytes.

Papadakis KA, Krempski J, Reiter J, Svingen P, Xiong Y, Sarmento OF, Huseby A, Johnson AJ, Lomberk GA, Urrutia RA, Faubion WA.

Am J Physiol Cell Physiol. 2015 Mar 1;308(5):C362-71. doi: 10.1152/ajpcell.00262.2014. Epub 2014 Dec 3.

Supplemental Content

Support Center